497 Precision Medicine and Cancer

Wednesday, November 18, 2020: 8:00 AM - 9:00 AM
Chemical Engineers in Medicine (TF) (PreRecorded+)

Description:
Chemical engineers are uniquely positioned to advance the precision of medicine. This session focuses on these advances.

Sponsor:
Chemical Engineers in Medicine
Chair:
Sammy S. Datwani Email: sammy.datwani@labcyte.com
Co-Chair:
Thomas Zangle Email: tzangle@chemeng.utah.edu


(497a) Multi-Modal Single-Cell Analysis As a Basis for Precision Therapy Targeting Intratumoral Heterogeneity in Glioblastoma
James Park, Adrian Lopez Garcia de Lomana, Anoop Patel and Nitin Baliga


(497b) Modeling and Manufacturing Methods for Downsizing a Centrifugal Bioreactor for Use in Cancer Immunotherapy
Kitana M. Kaiphanliam, Brenden Fraser-Hevlin, David B. Thiessen and Bernard J. Van Wie


(497c) TGF-β Inhibition Combined with Cytotoxic Nanomedicine Normalizes Triple Negative Breast Cancer Microenvironment Towards Anti-Tumor Immunity
Margaret R. Martin, Myrofora Panagi, Horacio Cabral and Triantafyllos Stylianopoulos


(497d) Unveiling the Cell Cycle Mediated Apoptosis Mechanism and Therapeutic Efficacy in Breast Cancer Cells
Muhammad Raisul Abedin and Sutapa Barua


(497e) Measurement of Cancer Cell Drug Response with Quantitative Phase Imaging
Edward Polanco, Tarek Moustafa, Tyler Bodily and Thomas Zangle


(497f) Synergistic Combinations Using APE1 Inhibitors for Ablation of Advanced Melanoma
Rajeshwar Nitiyanandan, Sheba Goklany, Daniel Julien, Deepanjan Ghosh, Alexander Maltagliati, Sudhakar Godeshala, David DiCaudo and Kaushal Rege


(497g) Efficient and Safe Delivery of Cancer Chemotherapeutics By DNA Fragments
Saad Mohammad, Jee Young Chung, Ik-Soo Kim and Young Jik Kwon


(497h) Programming Structure-Function Relationships in Protein Megamolecules for Prodrug Cancer Therapy
Blaise Kimmel, Kevin Metcalf, Daniel Sykora, Justin Modica, Kelly Parker, Raymond Dai, Vinayak P. Dravid, Zena Werb and Milan Mrksich


(497i) Point-of-Care Low-Cost Cancer Therapeutic Production and Monitoring Efficacy in Human Serum with Cell-Free Protein Synthesis: Toward on‐Demand Treatment of ALL
Bradley C. Bundy and J Porter Hunt
See more of this Group/Topical: Topical Conference: Chemical Engineers in Medicine
<< Previous Session | Next Session >>